Industry
Beam Therapeutics Inc [BEAM] Is Currently 25.89 below its 200 Period Moving Avg: What Does This Mean?
Beam Therapeutics Inc [NASDAQ: BEAM] closed the trading session at $45.07. The company report on February 27, 2024 at 6:30 AM that Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones. Patient Dosing and Enrollment Continue to Progress in Beacon
